Study identifier:D133FR00236
ClinicalTrials.gov identifier:NCT07316062
EudraCT identifier:N/A
CTIS identifier:N/A
A Multi-centre Chart Review study on the treatment patterns and outcomes of stage I-III Non-Small Cell Lung Cancer in China
non-small-cell lung
N/A
No
-
All
3000
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 May 2026 by AstraZeneca
AstraZeneca
-
No locations available
| Arms | Assigned Interventions |
|---|